Peipei Ye
Overview
Explore the profile of Peipei Ye including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
43
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cheng Y, Xu S, Pei R, Chen D, Du X, Li S, et al.
Transfus Apher Sci
. 2025 Feb;
64(3):104096.
PMID: 39983375
Background: In multiple myeloma (MM) or lymphoma with poor mobilization, the combination of etoposide, cytarabine (Ara-C), and pegfilgrastim (EAP) appears to have higher mobilization efficacy than cyclophosphamide (Cy) plus granulocyte...
2.
Zhuang H, Li F, Pei R, Jiang X, Chen D, Li S, et al.
Biochem Genet
. 2025 Jan;
PMID: 39820826
Acute myeloid leukemia (AML) with a normal karyotype (CN-AML) constitutes approximately 50% of all AML cases, presenting significant prognostic variability, and highlighting the urgent need for the identification of novel...
3.
Lu Y, Jiang X, Li Y, Li F, Zhao M, Lin Y, et al.
J Transl Med
. 2024 Sep;
22(1):867.
PMID: 39334157
Background: Acute myeloid leukaemia (AML) comprises a group of heterogeneous and aggressive haematological malignancies with unsatisfactory prognoses and limited treatment options. Treatments targeting B-cell lymphoma-2 (BCL-2) with venetoclax have been...
4.
Cao J, Zhuang X, Pei R, Lu Y, Ye P, Chen D, et al.
Curr Res Transl Med
. 2024 Sep;
72(4):103473.
PMID: 39326334
Granulocyte colony-stimulating factor (G-CSF) mobilized peripheral blood stem cells have become the preferred source of hematopoietic stem cells. We compared the effectiveness of G-CSF and pegylated G-CSF (peg-G-CSF) for hematopoietic...
5.
Lian J, Zhuang H, Li F, Pei R, Chen D, Ye P, et al.
Hematology
. 2024 Aug;
29(1):2381171.
PMID: 39087796
Background: Acute myeloid leukemia (AML) is a heterogeneous disease, for which identifying reliable prognostic markers is critical for accurate clinical prognosis and treatment optimization. The inhibition of emopamil-binding protein gene...
6.
Xiao C, Guo H, Li R, Wang Y, Yin K, Ye P, et al.
Plant Physiol
. 2024 Jul;
196(2):1579-1594.
PMID: 39041424
Drought stress inhibits plant growth and agricultural production. Improving plant instantaneous water use efficiency (iWUE), which is strictly regulated by stomata, is an effective way to cope with drought stress....
7.
Cen T, Zhang Q, Ying Y, Chen Z, Zhang X, Wu X, et al.
Medicine (Baltimore)
. 2024 Jun;
103(24):e38406.
PMID: 38875392
Rationale: Pleural effusion, especially bilateral bloody pleural effusion, is a rare complication of Waldenström macroglobulinemia (WM). Pleural effusion in patients with WM has many causes, such as infection, tumor invasion...
8.
Ye P, Wu M, Cao J, Pei R, Yuan J, Zhuang H, et al.
Ann Hematol
. 2024 May;
103(8):3135-3143.
PMID: 38809457
Methods: We retrospectively analyzed outcomes in 55 patients ≥ 55 years of age with hematologic malignancies treated with fludarabine, cytarabine, busulfan, and low-dose cyclophosphamide as the conditioning regimen between January...
9.
Ye P, Cheng Y, Lian J, Tong H, Li L, Guo Q, et al.
Br J Haematol
. 2024 Feb;
204(6):2342-2350.
PMID: 38400570
A chemotherapy-based mobilization regimen in patients who mobilize poorly, based on etoposide, cytarabine and pegfilgrastim (EAP), has recently been introduced. The aim of this prospective study was to investigate the...
10.
Li Y, Zhao M, Lin Y, Jiang X, Jin L, Ye P, et al.
Eur J Pharmacol
. 2024 Feb;
968:176418.
PMID: 38350590
The management of patients with acute myeloid leukemia (AML) remains a challenge because of the complexity and heterogeneity of this malignancy. Despite the recent approval of several novel targeted drugs,...